Matriptase is synthesized as a zymogen, which can be activated via proteolytic cleavage by other proteases, for example by Tmprss2, enhancing its effect on the growth and invasiveness of prostate cancer [58]. This evidence concerns the gene TMPRSS2 and prostate cancer.